- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02460718
ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama (ENCOURAGE)
Study Overview
Detailed Description
The purpose of this project was to provide robust evidence on the effectiveness of a peer support intervention in improving diabetes outcomes by conducting a group-randomized, controlled implementation trial of a volunteer peer support intervention.
The study had three specific aims:
Aim 1. In Phase I (months 0-8), to perform a qualitative needs assessment with peer advisors and health care providers to inform peer advisor roles and responsibilities (i.e., the intervention) and peer advisor recruitment strategies, curriculum and training; and patient recruitment plans.
Aim 2. Also in Phase I, to pilot our collaboratively developed intervention and, based on pilot test results, to recruit and train peer advisors for the intervention, and begin patient recruitment.
Aim 3. In Phase II (months 9-32), conduct the group randomized implementation trial and evaluate it using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 19 or older in age, diagnosed with diabetes, under the care of a doctor
Exclusion Criteria:
- not community dwelling, less than 19 years old, pregnant, end-stage medical conditions with limited life expectancy, no access to telephone, does not speak english
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
Participants received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit.
Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight.
|
|
|
Experimental: Encourage study
Participants in the intervention arm were paired with a peer coach, interacting by telephone weekly for the first 8 weeks and then monthly for a total of 10 months. Participants also received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit. Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight. |
This intervention tested the effects of a peer coaching program plus brief diabetes education versus brief diabetes education alone on diabetes outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycated hemoglobin (A1c)
Time Frame: Change in A1c in 12 months
|
fingerstick, point-of-care a1c test
|
Change in A1c in 12 months
|
|
Blood pressure
Time Frame: Change in blood pressure measure in 12 months
|
Measured using digital automated blood pressure monitor
|
Change in blood pressure measure in 12 months
|
|
LDL cholesterol
Time Frame: Change in LDL cholesterol in 12 month
|
measured using finger stick, spectrophotometer to measure LDL cholesterol
|
Change in LDL cholesterol in 12 month
|
|
diabetes self-care behaviors questionnaire
Time Frame: Change in diabetes self-care behaviors at 12 months
|
aspects of diabetes self-management such as taking medications as directed, self-report of exercise, and eating behaviors
|
Change in diabetes self-care behaviors at 12 months
|
|
depressive symptoms
Time Frame: change in depressive symptoms at 12 months
|
self-report using Patient Health Questionnaire 8 (PHQ8)
|
change in depressive symptoms at 12 months
|
|
quality of life
Time Frame: Change in quality of life measures at 12 months
|
self-report using Short form-1 (SF1), and Euroquol (EQ-5D)
|
Change in quality of life measures at 12 months
|
|
patient activation
Time Frame: change in patient activation in 12 months
|
self-report using the 13 item Patient Activation Measure (PAM13)
|
change in patient activation in 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
body mass index
Time Frame: change in BMI in 12 months
|
weight measured using digital scale, height measured using stadiometer
|
change in BMI in 12 months
|
|
diabetes knowledge
Time Frame: change in diabetes knowledge in 12 months
|
assessed using the Spoken Knowledge in Low Literacy in Diabetes Scale
|
change in diabetes knowledge in 12 months
|
|
trust in physicians
Time Frame: change in trust in physicians in 12 months
|
assessed using the Trust in Physicians Scale
|
change in trust in physicians in 12 months
|
|
composite measure of healthcare utilization
Time Frame: Change in health care utilization in 12 months
|
self-report by participant, number of times utilized healthcare services
|
Change in health care utilization in 12 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- T0808270039
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and Digestive...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Leiden University Medical CenterAndaluz Health ServiceCompletedDiabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes MellitusNetherlands, Spain
Clinical Trials on ENCOURAGE Study
-
Indiana UniversityIndiana University HealthCompletedDiabetes Mellitus, Type 2 | Prediabetic StateUnited States
-
St. Boniface HospitalHeart and Stroke Foundation Manitoba; Tactica Interactive WinnipegUnknownPhysical Activity | Sedentary LifestyleCanada
-
University of StrathclydeNHS Greater Glasgow and ClydeNot yet recruiting
-
Northwestern UniversityNational Institute on Aging (NIA)CompletedAnnual Wellness VisitUnited States
-
University of VermontGameTheoryCompletedObesity | Physical ActivityUnited States
-
AdventHealthCompletedHypertensionUnited States
-
Mahidol UniversityEnrolling by invitationSarcopenia | Cirrhosis, Liver | Daily Step CountThailand
-
University of LouisvilleOatly Group ABRecruitingDietary Habits | Food Preferences | Food NeophobiaUnited States
-
Mahidol UniversityEnrolling by invitationBMI | Metabolic Syndrome | Insulin Resistance | NAFLD | Genetic Polymorphism | Cardiovascular Disease (CVD) | MASLD | Daily Step CountThailand